News | November 14, 2014

System named tops in five categories, including higher marks for pharmacy interfaces

 Elekta.Mosaiq

November 14, 2014 — According to a survey by KLAS, an independent research firm, Elekta's Mosaiq Oncology Information System earned the No. 1 ranking in the medical and/or radiology oncology category of KLAS' "Oncology 2014: Integration is Key" report. The survey of 247 customers of various vendors said that "Elekta has improved their Mosaiq interfaces to take a commanding lead over their competitors." Mosaiq scored 82.4 out of 100, 93 percent of customers said they would buy again and 96 percent confirmed that Mosaiq is part of their long-term plans.

This is the second year that it has received this recognition. It was also ranked highest in the KLAS' "Oncology 2013: Eyes Wide Open" report.

This year, the report indicated that in the "interface race," in which integration is more critical than functionality in the eyes of customers, providers were more pleased with Elekta's Mosaiq pharmacy interfaces than they were in the 2013 KLAS oncology report, achieving a rating of 8.0, eclipsing last year's mark of 7.1. "Elekta's single database for radiation and medical oncology continues to be a strength for the continuity of oncology care," the report states.

The survey also revealed high customer appreciation for the improved workflow automation that Elekta provides in Mosaiq via IQ Scripts, which "has been immensely helpful in speeding up workflow."

In the report, Mosaiq was the highest performer in five out of eight categories, covering both medical and radiation oncology.

Mosaiq is a complete patient information management system that efficiently manages patient care on a single solution, allowing effective treatment evaluation before, during and after delivery to ensure accuracy and safety. With more than 25 years of open systems support, Mosaiq connects seamlessly to virtually any linear accelerator and planning system from any vendor, giving centers the flexibility to choose solutions that perform optimally for their practice and patients.

For more information: www.elekta.com


Related Content

News | Artificial Intelligence

March 28, 2024 — As artificial intelligence (AI) makes its way into cancer care – and into discussions between ...

Time March 28, 2024
arrow
News | Prostate Cancer

March 27, 2024 — A minimally invasive treatment using MRI and transurethral ultrasound instead of surgery or radiation ...

Time March 27, 2024
arrow
Videos | Radiation Oncology

In the conclusion of this 3-part video series on recent advancements in diagnostic radiology, current editorial advisory ...

Time March 19, 2024
arrow
News | Breast Imaging

March 18, 2024 — QT Imaging Holdings, Inc., a medical device company engaged in research, development, and ...

Time March 18, 2024
arrow
Feature | Radiation Oncology | By Christine Book

Appreciating the considerable advances in the clinical application of artificial intelligence (AI) within healthcare ...

Time March 06, 2024
arrow
News | FDA

March 1, 2024 — Varian, a Siemens Healthineers company, announced that it has received 510(k) clearance from the U.S ...

Time March 01, 2024
arrow
News | Breast Imaging

February 22, 2024 — The FAST-Forward randomized trial from the UK found that ultrahypofractionated whole breast ...

Time February 22, 2024
arrow
News | Radiation Oncology

February 22, 2024 — The National Institutes of Health has launched a clinical trials network to evaluate emerging ...

Time February 22, 2024
arrow
News | Radiation Oncology

February 14, 2024 — Accuray Incorporated announced that the team at Quebec’s Montérégie Integrated Cancer Center, part ...

Time February 14, 2024
arrow
News | Radiation Oncology

February 12, 2024 — Radformation, a global pioneer in radiation oncology software solutions, is pleased to announce its ...

Time February 12, 2024
arrow
Subscribe Now